Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon α for chronic hepatitis C
- 1 July 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 39 (1), 106-111
- https://doi.org/10.1016/s0168-8278(03)00187-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)Journal of Hepatology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Clinical laboratory evaluation of a new sensitive and specific assay for qualitative detection of hepatitis C virus RNA in clinical specimensJournal of Hepatology, 2000
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and CirrhosisNew England Journal of Medicine, 2000
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CNew England Journal of Medicine, 2000
- Impact of Interferon Alfa–2B and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis CHepatology, 2000
- Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assaysHepatology, 2000
- Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferonJournal of Hepatology, 1999
- The Natural History of Community-Acquired Hepatitis C in the United StatesNew England Journal of Medicine, 1992
- Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.Proceedings of the National Academy of Sciences, 1990